Fenwick & West represented BioAge Labs in the transaction. BioAge Labs (BioAge) announced it completed the oversubscribed $170M Series D financing round led by Sofinnova Investments...
You must be a Standard 1 Year member to access this content.
Fenwick represented Abdera Therapeutics on the deal. Abdera Therapeutics, a biopharmaceutical company leveraging its advanced antibody engineering ROVEr™ platform to design and develop tunable, precision radiopharmaceuticals...
You must be a Standard 1 Year member to access this content.
Fenwick represented Malwarebytes on the deal while Paul Hastings LLP represented Vector Capital. Malwarebytes, a company specializing in real-time cyberprotection, announced its strategic $100 million minority investment...
You must be a Standard 1 Year member to access this content.
Fenwick represented Cleerly on the deal. Cleerly, a company creating a new standard of care for heart disease, announced its $192 million Series C financing. This new...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Persefoni on the deal. Persefoni, a climate tech management and accounting platform for enterprises and financial institutions, announced its $101 million Series...
You must be a Standard 1 Year member to access this content.
Fenwick & West LLP advised Dragos on the deal. Dragos, a global leader in cybersecurity for industrial controls systems/operational technology environments, announced its $200 million Series D...
You must be a Standard 1 Year member to access this content.
